Insulin Glargine 4002 Study Investigators: The treat-to-target trial: trandomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. - Riddle,M.C.; Rosenstock,J.; Gerich,J. (Diabetes Care, 2003)